Evogene Ltd. (TLV:EVGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 233.00
-3.10 (-1.31%)
Apr 29, 2026, 12:23 PM IDT
Evogene Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 3.85 | 5.58 | 2.98 | 1.68 | 0.93 | Upgrade
|
| Revenue Growth (YoY) | -30.91% | 87.02% | 78.03% | 80.11% | -10.58% | Upgrade
|
| Cost of Revenue | 4.09 | 2.38 | 1.49 | 0.91 | 0.77 | Upgrade
|
| Gross Profit | -0.24 | 3.2 | 1.49 | 0.77 | 0.16 | Upgrade
|
| Selling, General & Admin | 5.76 | 8.98 | 7.53 | 10.42 | 9.99 | Upgrade
|
| Research & Development | 7.99 | 12.51 | 16.2 | 20.79 | 21.13 | Upgrade
|
| Other Operating Expenses | -0.21 | - | - | -3.5 | - | Upgrade
|
| Operating Expenses | 13.55 | 21.49 | 23.72 | 27.71 | 31.12 | Upgrade
|
| Operating Income | -13.79 | -18.29 | -22.23 | -26.94 | -30.95 | Upgrade
|
| Interest Expense | -0.16 | -0.06 | -0.11 | -0.17 | -0.32 | Upgrade
|
| Interest & Investment Income | 0.36 | 0.82 | 0.98 | 0.18 | 0.29 | Upgrade
|
| Earnings From Equity Investments | -0.04 | -0.04 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.29 | -0.08 | -0.22 | -1.74 | 1.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.67 | 3.36 | -0.4 | -0.37 | -0.46 | Upgrade
|
| EBT Excluding Unusual Items | -13.25 | -14.29 | -21.99 | -29.03 | -30.37 | Upgrade
|
| Merger & Restructuring Charges | - | -0.51 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.05 | -0.72 | -0.06 | Upgrade
|
| Asset Writedown | -0.25 | - | - | - | - | Upgrade
|
| Pretax Income | -13.5 | -14.81 | -21.95 | -29.75 | -30.43 | Upgrade
|
| Income Tax Expense | 0 | 0.01 | 0.02 | 0.09 | 0.01 | Upgrade
|
| Earnings From Continuing Operations | -13.5 | -14.82 | -21.97 | -29.84 | -30.45 | Upgrade
|
| Earnings From Discontinued Operations | 5.67 | -3.24 | -3.99 | - | - | Upgrade
|
| Net Income to Company | -7.83 | -18.05 | -25.95 | -29.84 | -30.45 | Upgrade
|
| Minority Interest in Earnings | -0.66 | 1.57 | 2.08 | 3.21 | 2.65 | Upgrade
|
| Net Income | -8.49 | -16.49 | -23.88 | -26.64 | -27.79 | Upgrade
|
| Net Income to Common | -8.49 | -16.49 | -23.88 | -26.64 | -27.79 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 6 | 5 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 6 | 5 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 38.21% | 24.14% | 10.80% | 2.44% | 43.59% | Upgrade
|
| EPS (Basic) | -1.08 | -2.89 | -5.20 | -6.43 | -6.87 | Upgrade
|
| EPS (Diluted) | -1.08 | -2.89 | -5.20 | -6.43 | -6.87 | Upgrade
|
| Free Cash Flow | -13.64 | -20.33 | -22.15 | -24.85 | -25.56 | Upgrade
|
| Free Cash Flow Per Share | -1.73 | -3.57 | -4.83 | -6.00 | -6.32 | Upgrade
|
| Gross Margin | -6.25% | 57.33% | 50.03% | 45.73% | 17.53% | Upgrade
|
| Operating Margin | -357.85% | -327.95% | -745.51% | -1608.42% | -3328.28% | Upgrade
|
| Profit Margin | -220.22% | -295.59% | -800.77% | -1590.33% | -2988.49% | Upgrade
|
| Free Cash Flow Margin | -353.93% | -364.46% | -742.92% | -1483.52% | -2748.71% | Upgrade
|
| EBITDA | -13.26 | -17.71 | -20.93 | -24.36 | -28.72 | Upgrade
|
| D&A For EBITDA | 0.52 | 0.58 | 1.3 | 2.58 | 2.23 | Upgrade
|
| EBIT | -13.79 | -18.29 | -22.23 | -26.94 | -30.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.